news
microRNA reduces stroke risk
The molecule microRNA-210 stabilises deposits in the carotid artery and can thus prevent them from tearing, and prevent dangerous blood clots from forming.
List view / Grid view
microRNA
news
Update on Charles River’s collaboration with Moderna Therapeutics
Charles River Laboratories has provided a progress update related to its support of Moderna Therapeutics’ nonclinical discovery and development efforts...
news
EBV-derived microRNAs silence immune alarm signals of the host cell
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The virus drives production of small molecules, so-called microRNAs, which suppress alarm signals sent out by the infected cell...
article
Moderna discuss mRNA therapeutics in cystic fibrosis
22 July 2016 | By Victoria White, Digital Content Producer
Drug Target Review recently caught up with Lorence Kim, Chief Financial Officer of Moderna, to find out more about the company‘s collaboration with Vertex and using mRNA therapeutics to treat patients with cystic fibrosis...
news
Vertex and Moderna to develop cystic fibrosis mRNA Therapeutics
6 July 2016 | By Victoria White, Digital Content Producer
Their collaboration will focus on the use of mRNA therapies to enable cells in the lungs to produce functional copies of the CFTR protein...
news
Ethris publishes mRNA therapy musculoskeletal regeneration data
21 March 2016 | By Victoria White
Ethris has announced the publication of data that underlines the broad therapeutic potential of the company’s proprietary mRNA transcript therapy platform...